TipRanks
CytomX Therapeutics Inc (DE:6C1)
FRANKFURT:6C1
Germany Market
6C1
CytomX Therapeutics
RESEARCH TOOLSreports

CytomX Therapeutics (6C1) Income Statement

6 Followers

CytomX Therapeutics Income Statement

Last quarter (Q2 2026), CytomX Therapeutics's total revenue was $1.42M, a decrease of -92.40% from the same quarter last year. In Q2, CytomX Therapeutics's net income was $-20.67M. See CytomX Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 76.20M$ 138.10M$ 101.21M$ 53.16M$ 37.31M
Gross Profit
$ 76.20M$ 138.10M$ 101.21M$ 53.16M$ 37.31M
Operating Expenses
$ 98.56M$ 113.11M$ 107.70M$ 154.50M$ 153.35M
Depreciation and Amortization
$ 1.38M$ 1.77M$ 2.17M$ 2.44M$ 2.71M
EBITDA
$ -15.75M$ 33.86M$ 5.50M$ -96.87M$ -113.16M
Operating Income
$ -22.36M$ 25.00M$ -6.48M$ -101.33M$ -116.04M
Other Income/Expenses
$ 5.23M$ 7.10M$ 9.81M$ 2.02M$ 172.00K
Pretax Income
$ -17.13M$ 32.09M$ 3.32M$ -99.32M$ -115.87M
Net Income
$ -17.37M$ 31.87M$ -569.00K$ -99.32M$ -115.87M
Per Share Metrics
Basic EPS
$ -0.15$ 0.38$ >-0.01$ -1.48$ -1.26
Diluted EPS
$ -0.15$ 0.38$ >-0.01$ -1.48$ -1.26
Weighted Average Shares Outstanding
 137.94M 84.44M 73.81M 65.74M 64.15M
Weighted Average Shares Outstanding (Diluted)
 137.94M 84.75M 73.81M 65.74M 64.15M
Currency in USD

CytomX Therapeutics Earnings and Revenue History